| 1. Yamamoto K, Ooizumi H, Umesono K, Verstuyf A, Bouillon R, DeLuca HF, Shinki T, Suda T, Yamada S.. (1999) Three-dimensional structure-function relationship of vitamin D: side chain location and various activities., 9 (7): [PMID:10230636] [10.1016/s0960-894x(99)00129-8] |
| 2. Suhara Y, Nihei KI, Tanigawa H, Fujishima T, Konno K, Nakagawa K, Okano T, Takayama H.. (2000) Syntheses and biological evaluation of novel 2alpha-substituted 1alpha,25-dihydroxyvitamin D3 analogues., 10 (10): [PMID:10843234] [10.1016/s0960-894x(00)00189-x] |
| 3. Yamada S, Yamamoto K, Naito H, Suzuki T, Ohmori M, Takayama H, Shiina Y, Miyaura C, Tanaka H, Abe E.. (1985) Syntheses and differentiating action of vitamin D endoperoxides. Singlet oxygen adducts of vitamin D derivatives in human myeloid leukemia cells (HL-60)., 28 (9): [PMID:2993611] [10.1021/jm00147a005] |
| 4. Ono Y, Watanabe H, Akira K, Kubodera N, Okano T, Tsugawa N, Kobayashi T. (1994) Synthesis and biological character of 1-hydroxylated vitamin D3 Analogues, 4 (12): [10.1016/S0960-894X(01)80525-4] |
| 5. Konno K, Maki S, Fujishima T, Liu Z, Miura D, Chokki M, Takayama H.. (1998) A novel and practical route to A-ring enyne synthon for 1 alpha,25-dihydroxyvitamin D3 analogs: synthesis of A-ring diastereomers of 1 alpha,25-dihydroxyvitamin D2 and 3-methyl-1,25-dihydroxyvitamin D3., 8 (2): [PMID:9871644] [10.1016/s0960-894x(97)10204-9] |
| 6. Wu Y, Sabbe K, De Clercq P, Vandewalle M, Bouillon R, Verstuyf A.. (2002) Vitamin D(3): synthesis of seco C-9,11,21-trisnor-17-methyl-1 alpha, 25-dihydroxyvitamin D(3) analogues., 12 (12): [PMID:12039578] [10.1016/s0960-894x(02)00221-4] |
| 7. Wu Y, De Clercq P, Vandewalle M, Bouillon R, Verstuyf A.. (2002) Vitamin D(3): synthesis of seco-C-9,11-bisnor-17-methyl-1 alpha,25-dihydroxyvitamin D(3) analogues., 12 (12): [PMID:12039579] [10.1016/s0960-894x(02)00222-6] |
| 8. Posner GH, Halford BA, Peleg S, Dolan P, Kensler TW.. (2002) Conceptually new low-calcemic oxime analogues of the hormone 1 alpha,25-dihydroxyvitamin D(3): synthesis and biological testing., 45 (8): [PMID:11931627] [10.1021/jm010560o] |
| 9. Kobayashi T, Okano T, Tsugawa N, Murano M, Masuda S, Takeuchi A, Sato K, Nishii Y. (1993) 2-(3-hydroxypropoxy)-1,25-dihydroxyvitamin D3 (ED-71), preventive and therapeutic effects on bone mineral loss in ovariectomized rats, 3 (9): [10.1016/S0960-894X(00)80111-0] |
| 10. Goff JP, Horst RL, Uskokovic M. (1993) 1,25,28-trihydroxyvitamin D2 up-regulates renal vitamin D receptor without causing hypercalcemia, 3 (9): [10.1016/S0960-894X(00)80113-4] |
| 11. Masuno H, Yamamoto K, Wang X, Choi M, Ooizumi H, Shinki T, Yamada S.. (2002) Rational design, synthesis, and biological activity of novel conformationally restricted vitamin D analogues, (22R)- and (22S)-22-ethyl-1,25-dihydroxy-23,24-didehydro-24a,24b-dihomo-20-epivitamin D(3)., 45 (9): [PMID:11960494] [10.1021/jm0105631] |
| 12. Posner GH, Guyton KZ, Kensler TW, Barsony J, Lieberman ME, Reddy G, Clark JW, Wankadiya KF, Tserng K. (1993) 1-(hydroxyalkyl)-25-hydroxyvitamin D3 analogs of calcitriol. 2. Preliminary biological evaluation, 3 (9): [10.1016/S0960-894X(00)80115-8] |
| 13. Calverley MJ, Binderup L. (1993) Synthesis and biological evaluation of MC 1357, a new 20-epi-23-oxa-1,25-dihydroxy-vitamin D3 analogue with potent non-classical effects, 3 (9): [10.1016/S0960-894X(00)80117-1] |
| 14. Binderup L. (1993) Vitamin D analogues: new regulators of cancer cell growth and differentiation, 3 (9): [10.1016/S0960-894X(00)80126-2] |
| 15. Fujishima T, Liu Z, Miura D, Chokki M, Ishizuka S, Konno K, Takayama H.. (1998) Synthesis and biological activity of 2-methyl-20-epi analogues of 1 alpha,25-dihydroxyvitamin D3., 8 (16): [PMID:9873502] [10.1016/s0960-894x(98)00363-1] |
| 16. Posner GH, Lee JK, Li Z, Takeuchi K, Guggino SE, Dolan P, Kensler TW. (1995) 1,25-Dihydroxyvitamin D3 Hybrid Analogs with Structural changes at both the A-ring and the C,D-ring side-chain. II, 5 (18): [10.1016/0960-894X(95)00376-5] |
| 17. Maynard DF, Trankle WG, Norman AW, Okamura WH.. (1994) 14-epi stereoisomers of 25-hydroxy- and 1 alpha,25-dihydroxyvitamin D3: synthesis, isomerization to previtamins, and biological studies., 37 (15): [PMID:8057286] [10.1021/jm00041a017] |
| 18. Figadère B, Norman AW, Henry HL, Koeffler HP, Zhou JY, Okamura WH.. (1991) Arocalciferols: synthesis and biological evaluation of aromatic side-chain analogues of 1 alpha,25-dihydroxyvitamin D3(1a)., 34 (8): [PMID:1652020] [10.1021/jm00112a021] |
| 19. Norman AW, Manchand PS, Uskokovic MR, Okamura WH, Takeuchi JA, Bishop JE, Hisatake JI, Koeffler HP, Peleg S.. (2000) Characterization of a novel analogue of 1alpha,25(OH)(2)-vitamin D(3) with two side chains: interaction with its nuclear receptor and cellular actions., 43 (14): [PMID:10893309] [10.1021/jm0000160] |
| 20. Yamamoto K, Sun WY, Ohta M, Hamada K, DeLuca HF, Yamada S.. (1996) Conformationally restricted analogs of 1 alpha, 25-dihydroxyvitamin D3 and its 20-epimer: compounds for study of the three-dimensional structure of vitamin D responsible for binding to the receptor., 39 (14): [PMID:8709103] [10.1021/jm9600048] |
| 21. Thacher SM, Vasudevan J, Tsang KY, Nagpal S, Chandraratna RA.. (2001) New dermatological agents for the treatment of psoriasis., 44 (3): [PMID:11462969] [10.1021/jm0000214] |
| 22. Posner GH, Lee JK, Wang Q, Peleg S, Burke M, Brem H, Dolan P, Kensler TW.. (1998) Noncalcemic, antiproliferative, transcriptionally active, 24-fluorinated hybrid analogues of the hormone 1alpha, 25-dihydroxyvitamin D3. Synthesis and preliminary biological evaluation., 41 (16): [PMID:9685240] [10.1021/jm980031t] |
| 23. Suhara Y, Kittaka A, Kishimoto S, Calverley MJ, Fujishima T, Saito N, Sugiura T, Waku K, Takayama H.. (2002) Synthesis and testing of 2alpha-modified 1alpha,25-dihydroxyvitamin D(3) analogues with a double side chain: marked cell differentiation activity., 12 (22): [PMID:12392726] [10.1016/s0960-894x(02)00722-9] |
| 24. Sicinski RR, Rotkiewicz P, Kolinski A, Sicinska W, Prahl JM, Smith CM, DeLuca HF.. (2002) 2-Ethyl and 2-ethylidene analogues of 1alpha,25-dihydroxy-19-norvitamin D(3): synthesis, conformational analysis, biological activities, and docking to the modeled rVDR ligand binding domain., 45 (16): [PMID:12139448] [10.1021/jm020007m] |
| 25. Posner GH, Wang Q, Han G, Lee JK, Crawford K, Zand S, Brem H, Peleg S, Dolan P, Kensler TW.. (1999) Conceptually new sulfone analogues of the hormone 1alpha, 25-dihydroxyvitamin D(3): synthesis and preliminary biological evaluation., 42 (18): [PMID:10479276] [10.1021/jm990267c] |
| 26. Honzawa S, Suhara Y, Nihei K, Saito N, Kishimoto S, Fujishima T, Kurihara M, Sugiura T, Waku K, Takayama H, Kittaka A.. (2003) Concise synthesis and biological activities of 2alpha-alkyl- and 2alpha-(omega-hydroxyalkyl)-20-epi-1alpha,25-dihydroxyvitamin D3., 13 (20): [PMID:14505658] [10.1016/s0960-894x(03)00739-x] |
| 27. Zhou X, Zhu GD, Van Haver D, Vandewalle M, De Clercq PJ, Verstuyf A, Bouillon R.. (1999) Synthesis, biological activity, and conformational analysis of four seco-D-15,19-bisnor-1alpha,25-dihydroxyvitamin D analogues, diastereomeric at C17 and C20., 42 (18): [PMID:10479287] [10.1021/jm980736v] |
| 28. Posner GH, Crawford K, Siu-Caldera ML, Reddy GS, Sarabia SF, Feldman D, van Etten E, Mathieu C, Gennaro L, Vouros P, Peleg S, Dolan PM, Kensler TW.. (2000) Conceptually new 20-epi-22-oxa sulfone analogues of the hormone 1alpha,25-dihydroxyvitamin D(3): synthesis and biological evaluation., 43 (19): [PMID:11000014] [10.1021/jm000215j] |
| 29. Oshida J, Okamoto M, Ishizuka S, Azuma S.. (1999) Synthesis and biological evaluation of 1alpha,24-dihydroxy-25-nitrovitamin D3., 9 (3): [PMID:10091688] [10.1016/s0960-894x(99)00013-x] |
| 30. Konno K, Fujishima T, Maki S, Liu Z, Miura D, Chokki M, Ishizuka S, Yamaguchi K, Kan Y, Kurihara M, Miyata N, Smith C, DeLuca HF, Takayama H.. (2000) Synthesis, biological evaluation, and conformational analysis of A-ring diastereomers of 2-methyl-1,25-dihydroxyvitamin D(3) and their 20-epimers: unique activity profiles depending on the stereochemistry of the A-ring and at C-20., 43 (22): [PMID:11063621] [10.1021/jm000261j] |
| 31. Sicinski RR, Perlman KL, Prahl J, Smith C, DeLuca HF.. (1996) Synthesis and biological activity of 1 alpha, 25-dihydroxy-18-norvitamin D3 and 1 alpha, 25-dihydroxy-18,19-dinorvitamin D3., 39 (22): [PMID:8893845] [10.1021/jm950745t] |
| 32. Posner GH, Li Z, White MC, Vinader V, Takeuchi K, Guggino SE, Dolan P, Kensler TW.. (1995) 1 alpha,25-dihydroxyvitamin D3 analogs featuring aromatic and heteroaromatic rings: design, synthesis, and preliminary biological testing., 38 (22): [PMID:7473581] [10.1021/jm00022a019] |
| 33. Sicinski RR, Prahl JM, Smith CM, DeLuca HF.. (1998) New 1alpha,25-dihydroxy-19-norvitamin D3 compounds of high biological activity: synthesis and biological evaluation of 2-hydroxymethyl, 2-methyl, and 2-methylene analogues., 41 (23): [PMID:9804706] [10.1021/jm9802618] |
| 34. Gill HS, Londowski JM, Corradino RA, Zinsmeister AR, Kumar R.. (1990) Synthesis and biological activity of novel vitamin D analogues: 24,24-difluoro-25-hydroxy-26,27-dimethylvitamin D3 and 24,24-difluoro-1 alpha,25-dihydroxy-26,27-dimethylvitamin D3., 33 (2): [PMID:2153815] [10.1021/jm00164a003] |
| 35. Marczak S, Przezdziecka A, Wicha J, Steinmeyer A, Zügel U.. (2001) Synthesis and biological activity of the 1alpha,25-dihydroxyvitamin D3 diastereomer with unnatural configuration at the rings C/D side-chain moiety., 11 (1): [PMID:11140735] [10.1016/s0960-894x(00)00598-9] |
| 36. Shimizu M, Iwasaki Y, Shimazaki M, Amano Y, Yamamoto K, Reischl W, Yamada S.. (2005) New derivatives of 1alpha,25-dihydroxy-19-norvitamin D3 with two substituents at C-2: synthesis and biological activity., 15 (5): [PMID:15713405] [10.1016/j.bmcl.2004.12.090] |
| 37. Schepens W, Van Haver DV, Vandewalle M, De Clercq PJ, Bouillon R, Verstuyf A.. (2004) Synthesis and biological activity of 22-oxa CD-ring modified analogues of 1alpha,25-dihydroxyvitamin D3: spiro[5.5]undecane CF-ring analogues., 14 (15): [PMID:15225691] [10.1016/j.bmcl.2004.05.058] |
| 38. Noguchi T, Miyachi H, Katayama R, Naito M, Hashimoto Y.. (2005) Cell differentiation inducers derived from thalidomide., 15 (13): [PMID:15936192] [10.1016/j.bmcl.2005.05.005] |
| 39. Yamamoto K, Abe D, Yoshimoto N, Choi M, Yamagishi K, Tokiwa H, Shimizu M, Makishima M, Yamada S.. (2006) Vitamin D receptor: ligand recognition and allosteric network., 49 (4): [PMID:16480267] [10.1021/jm050795q] |
| 40. Shimizu K, Kawase A, Haneishi T, Kato Y, Kinoshita K, Ohmori M, Furuta Y, Emura T, Kato N, Mitsui T, Yamaguchi K, Morita K, Sekiguchi N, Yamamoto T, Matsushita T, Shimaoka S, Sugita A, Morikawa K.. (2006) Design and evaluation of new antipsoriatic antedrug candidates having 16-en-22-oxa-vitamin D3 structures., 16 (12): [PMID:16630723] [10.1016/j.bmcl.2006.03.014] |
| 41. Peleg S, Petersen KS, Suh BC, Dolan P, Agoston ES, Kensler TW, Posner GH.. (2006) Low-calcemic, highly antiproliferative, 1-difluoromethyl hybrid analogs of the natural hormone 1alpha,25-dihydroxyvitamin D3: design, synthesis, and preliminary biological evaluation., 49 (25): [PMID:17149880] [10.1021/jm0609925] |
| 42. Yamamoto K, Inaba Y, Yoshimoto N, Choi M, DeLuca HF, Yamada S.. (2007) 22-Alkyl-20-epi-1alpha,25-dihydroxyvitamin D3 compounds of superagonistic activity: syntheses, biological activities and interaction with the receptor., 50 (5): [PMID:17298045] [10.1021/jm060889f] |
| 43. Maehr H, Uskokovic MR, Adorini L, Reddy GS.. (2004) Calcitriol derivatives with two different side chains at C-20. II. Diastereoselective syntheses of the metabolically produced 24(R)-hydroxygemini., 47 (26): [PMID:15588082] [10.1021/jm049340b] |
| 44. Kahraman M, Sinishtaj S, Dolan PM, Kensler TW, Peleg S, Saha U, Chuang SS, Bernstein G, Korczak B, Posner GH.. (2004) Potent, selective and low-calcemic inhibitors of CYP24 hydroxylase: 24-sulfoximine analogues of the hormone 1alpha,25-dihydroxyvitamin D(3)., 47 (27): [PMID:15615534] [10.1021/jm040129+] |
| 45. Petersen KS, Dolan PM, Kensler TW, Peleg S, Posner GH.. (2007) Low-calcemic, highly antiproliferative, 23-oxa ether analogs of the natural hormone 1 alpha,25-dihydroxyvitamin D3: design, synthesis, and preliminary biological evaluation., 50 (23): [PMID:17924616] [10.1021/jm070882d] |
| 46. Sicinski RR, Glebocka A, Plum LA, DeLuca HF.. (2007) Design, synthesis, and biological evaluation of a 1alpha,25-dihydroxy-19-norvitamin D3 analogue with a frozen A-ring conformation., 50 (24): [PMID:17960924] [10.1021/jm070635+] |
| 47. Matsuda H, Yoshida K, Miyagawa K, Asao Y, Takayama S, Nakashima S, Xu F, Yoshikawa M.. (2007) Rotenoids and flavonoids with anti-invasion of HT1080, anti-proliferation of U937, and differentiation-inducing activity in HL-60 from Erycibe expansa., 15 (3): [PMID:17158054] [10.1016/j.bmc.2006.09.024] |
| 48. Moda TL, Montanari CA, Andricopulo AD.. (2007) Hologram QSAR model for the prediction of human oral bioavailability., 15 (24): [PMID:17870541] [10.1016/j.bmc.2007.08.060] |
| 49. Hakamata W, Sato Y, Okuda H, Honzawa S, Saito N, Kishimoto S, Yamashita A, Sugiura T, Kittaka A, Kurihara M.. (2008) (2S,2'R)-analogue of LG190178 is a major active isomer., 18 (1): [PMID:18054230] [10.1016/j.bmcl.2007.11.007] |
| 50. Yoshimoto N, Inaba Y, Yamada S, Makishima M, Shimizu M, Yamamoto K.. (2008) 2-Methylene 19-nor-25-dehydro-1alpha-hydroxyvitamin D3 26,23-lactones: synthesis, biological activities and molecular basis of passive antagonism., 16 (1): [PMID:17904370] [10.1016/j.bmc.2007.09.017] |
| 51. Chen IS, Wu SJ, Tsai IL.. (1994) Chemical and bioactive constituents from Zanthoxylum simulans., 57 (9): [PMID:7798955] [10.1021/np50111a003] |
| 52. Shimizu M, Miyamoto Y, Takaku H, Matsuo M, Nakabayashi M, Masuno H, Udagawa N, DeLuca HF, Ikura T, Ito N.. (2008) 2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation, and crystal structure., 16 (14): [PMID:18539034] [10.1016/j.bmc.2008.05.043] |
| 53. Inaba Y, Yoshimoto N, Sakamaki Y, Nakabayashi M, Ikura T, Tamamura H, Ito N, Shimizu M, Yamamoto K.. (2009) A new class of vitamin D analogues that induce structural rearrangement of the ligand-binding pocket of the receptor., 52 (5): [PMID:19193059] [10.1021/jm8014348] |
| 54. Laverny G, Penna G, Uskokovic M, Marczak S, Maehr H, Jankowski P, Ceailles C, Vouros P, Smith B, Robinson M, Reddy GS, Adorini L.. (2009) Synthesis and anti-inflammatory properties of 1alpha,25-dihydroxy-16-ene-20-cyclopropyl-24-oxo-vitamin D3, a hypocalcemic, stable metabolite of 1alpha,25-dihydroxy-16-ene-20-cyclopropyl-vitamin D3., 52 (8): [PMID:19309155] [10.1021/jm801365a] |
| 55. Glebocka A, Sokolowska K, Sicinski RR, Plum LA, Deluca HF.. (2009) New 1alpha,25-dihydroxy-19-norvitamin D(3) compounds constrained in a single A-ring conformation: synthesis of the analogues by ring-closing metathesis route and their biological evaluation., 52 (11): [PMID:19402630] [10.1021/jm9001583] |
| 56. Chiellini G, Grzywacz P, Plum LA, Barycki R, Clagett-Dame M, DeLuca HF.. (2008) Synthesis and biological properties of 2-methylene-19-nor-25-dehydro-1alpha-hydroxyvitamin D(3)-26,23-lactones--weak agonists., 16 (18): [PMID:18722130] [10.1016/j.bmc.2008.08.011] |
| 57. Plonska-Ocypa K, Sicinski RR, Plum LA, Grzywacz P, Frelek J, Clagett-Dame M, DeLuca HF.. (2009) 13-Methyl-substituted des-C,D analogs of (20S)-1alpha,25-dihydroxy-2-methylene-19-norvitamin D3 (2MD): synthesis and biological evaluation., 17 (4): [PMID:19167893] [10.1016/j.bmc.2008.11.082] |
| 58. Maehr H, Lee HJ, Perry B, Suh N, Uskokovic MR.. (2009) Calcitriol derivatives with two different side chains at C-20. V. Potent inhibitors of mammary carcinogenesis and inducers of leukemia differentiation., 52 (17): [PMID:19685888] [10.1021/jm900780q] |
| 59. Barycki R, Sicinski RR, Plum LA, Grzywacz P, Clagett-Dame M, Deluca HF.. (2009) Removal of the 20-methyl group from 2-methylene-19-nor-(20S)-1alpha,25-dihydroxyvitamin D(3) (2MD) selectively eliminates bone calcium mobilization activity., 17 (22): [PMID:19819702] [10.1016/j.bmc.2009.09.047] |
| 60. Antony P, Sigüeiro R, Huet T, Sato Y, Ramalanjaona N, Rodrigues LC, Mouriño A, Moras D, Rochel N.. (2010) Structure-function relationships and crystal structures of the vitamin D receptor bound 2 alpha-methyl-(20S,23S)- and 2 alpha-methyl-(20S,23R)-epoxymethano-1 alpha,25-dihydroxyvitamin D3., 53 (3): [PMID:20070104] [10.1021/jm9014636] |
| 61. Sánchez-Abella L, Fernández S, Verstuyf A, Verlinden L, Gotor V, Ferrero M.. (2009) Synthesis, conformational analysis, and biological evaluation of 19-nor-vitamin D3 analogues with A-ring modifications., 52 (19): [PMID:19739672] [10.1021/jm900711d] |
| 62. Usera AR, Dolan P, Kensler TW, Posner GH.. (2009) 'Novel alkyl side chain sulfone 1alpha,25-dihydroxyvitamin D3 analogs: a comparison of in vitro antiproliferative activities and in vivo calcemic activities'., 17 (15): [PMID:19577932] [10.1016/j.bmc.2009.06.033] |
| 63. Lamblin M, Dabbas B, Spingarn R, Mendoza-Sanchez R, Wang TT, An BS, Huang DC, Kremer R, White JH, Gleason JL.. (2010) Vitamin D receptor agonist/histone deacetylase inhibitor molecular hybrids., 18 (11): [PMID:20452225] [10.1016/j.bmc.2010.03.078] |
| 64. Lamblin M, Spingarn R, Wang TT, Burger MC, Dabbas B, Moitessier N, White JH, Gleason JL.. (2010) An o-aminoanilide analogue of 1α,25-dihydroxyvitamin D(3) functions as a strong vitamin D receptor antagonist., 53 (20): [PMID:20883026] [10.1021/jm1007159] |
| 65. PubChem BioAssay data set, |
| 66. PubChem BioAssay data set, |
| 67. Grzywacz P, Chiellini G, Plum LA, Clagett-Dame M, DeLuca HF.. (2010) Removal of the 26-methyl group from 19-nor-1α,25-dihydroxyvitamin D₃ markedly reduces in vivo calcemic activity without altering in vitro VDR binding, HL-60 cell differentiation, and transcription., 53 (24): [PMID:21105677] [10.1021/jm1010447] |
| 68. Fourches D, Barnes JC, Day NC, Bradley P, Reed JZ, Tropsha A.. (2010) Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species., 23 (1): [PMID:20014752] [10.1021/tx900326k] |
| 69. Matthews EJ, Kruhlak NL, Weaver JL, Benz RD, Contrera JF.. (2004) Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling., 1 (4): [PMID:16472241] [10.2174/1570163043334794] |
| 70. Kruhlak NL, Choi SS, Contrera JF, Weaver JL, Willard JM, Hastings KL, Sancilio LF.. (2008) Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models., 18 (2): [PMID:20020916] [10.1080/15376510701857262] |
| 71. Unpublished dataset, |
| 72. Ray R, Lambert JR.. (2011) 1α,25-Dihydroxyvitamin D3-3β-bromoacetate, a potential cancer therapeutic agent: synthesis and molecular mechanism of action., 21 (8): [PMID:21392983] [10.1016/j.bmcl.2011.02.025] |
| 73. Regueira MA, Samanta S, Malloy PJ, Ordonez-Moran P, Resende D, Sussman F, Munoz A, Mourino A, Feldman D, Torneiro M.. (2011) Synthesis and biological evaluation of 1α,25-dihydroxyvitamin D(3) analogues hydroxymethylated at C-26., 54 (11): [PMID:21524075] [10.1021/jm200276y] |
| 74. Glebocka A, Sicinski RR, Plum LA, Deluca HF.. (2011) Synthesis and biological activity of 2-(3'-hydroxypropylidene)-1α-hydroxy-19-norvitamin D analogues with shortened alkyl side chains., 54 (19): [PMID:21902235] [10.1021/jm200743p] |
| 75. Demizu Y, Takahashi T, Kaneko F, Sato Y, Okuda H, Ochiai E, Horie K, Takagi K, Kakuda S, Takimoto-Kamimura M, Kurihara M.. (2011) Design, synthesis and X-ray crystallographic study of new nonsecosteroidal vitamin D receptor ligands., 21 (20): [PMID:21889334] [10.1016/j.bmcl.2011.08.047] |
| 76. Liu Z, Shi Q, Ding D, Kelly R, Fang H, Tong W.. (2011) Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps)., 7 (12): [PMID:22194678] [10.1371/journal.pcbi.1002310] |
| 77. Plonska-Ocypa K, Sibilska I, Sicinski RR, Sicinska W, Plum LA, DeLuca HF.. (2011) 13,13-Dimethyl-des-C,D analogues of (20S)-1α,25-dihydroxy-2-methylene-19-norvitamin D₃ (2MD): total synthesis, docking to the VDR, and biological evaluation., 19 (23): [PMID:22018918] [10.1016/j.bmc.2011.09.048] |
| 78. Banerjee U, Ghosh M, Kyle Hadden M.. (2012) Evaluation of vitamin D3 A-ring analogues as Hedgehog pathway inhibitors., 22 (3): [PMID:22226657] [10.1016/j.bmcl.2011.12.081] |
| 79. Wongmayura A, Fujii S, Ito S, Kano A, Taoda Y, Kawachi E, Kagechika H, Tanatani A.. (2012) Novel vitamin D receptor ligands bearing a spherical hydrophobic core structure--comparison of bicyclic hydrocarbon derivatives with boron cluster derivatives., 22 (4): [PMID:22285943] [10.1016/j.bmcl.2011.12.137] |
| 80. Salomón DG, Grioli SM, Buschiazzo M, Mascaró E, Vitale C, Radivoy G, Perez M, Fall Y, Mesri EA, Curino AC, Facchinetti MM.. (2011) Novel alkynylphosphonate analogue of calcitriol with potent antiproliferative effects in cancer cells and lack of calcemic activity., 2 (7): [PMID:24900339] [10.1021/ml200034w] |
| 81. Lu Y, Chen J, Janjetovic Z, Michaels P, Tang EK, Wang J, Tuckey RC, Slominski AT, Li W, Miller DD.. (2012) Design, synthesis, and biological action of 20R-hydroxyvitamin D3., 55 (7): [PMID:22404326] [10.1021/jm201478e] |
| 82. Kashiwagi H, Ono Y, Ohta M, Morikami K, Takahashi T.. (2012) Systematic SAR study of the side chain of nonsecosteroidal vitamin D₃ analogs., 20 (14): [PMID:22677528] [10.1016/j.bmc.2012.05.023] |
| 83. Flores A, Sicinski RR, Grzywacz P, Thoden JB, Plum LA, Clagett-Dame M, DeLuca HF.. (2012) A 20S combined with a 22R configuration markedly increases both in vivo and in vitro biological activity of 1α,25-dihydroxy-22-methyl-2-methylene-19-norvitamin D3., 55 (9): [PMID:22490010] [10.1021/jm300187x] |
| 84. USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date, |
| 85. Gándara Z, Pérez M, Salomón DG, Ferronato MJ, Fermento ME, Curino AC, Facchinetti MM, Gómez G, Fall Y.. (2012) Synthesis and biological evaluation of a new vitamin D2 analogue., 22 (19): [PMID:22926068] [10.1016/j.bmcl.2012.07.095] |
| 86. Ciesielski F, Sato Y, Chebaro Y, Moras D, Dejaegere A, Rochel N.. (2012) Structural basis for the accommodation of bis- and tris-aromatic derivatives in vitamin D nuclear receptor., 55 (19): [PMID:22957834] [10.1021/jm300858s] |
| 87. Carballa DM, Seoane S, Zacconi F, Pérez X, Rumbo A, Alvarez-Díaz S, Larriba MJ, Pérez-Fernández R, Muñoz A, Maestro M, Mouriño A, Torneiro M.. (2012) Synthesis and biological evaluation of 1α,25-dihydroxyvitamin D₃ analogues with a long side chain at C12 and short C17 side chains., 55 (20): [PMID:22989379] [10.1021/jm3008272] |
| 88. Batie S, Lee JH, Jama RA, Browder DO, Montano LA, Huynh CC, Marcus LM, Tsosie DG, Mohammed Z, Trang V, Marshall PA, Jurutka PW, Wagner CE.. (2013) Synthesis and biological evaluation of halogenated curcumin analogs as potential nuclear receptor selective agonists., 21 (3): [PMID:23276449] [10.1016/j.bmc.2012.11.033] |
| 89. PubChem BioAssay data set, |
| 90. Nakamura M, Makishima M, Hashimoto Y.. (2013) Development of silicon-containing bis-phenol derivatives as androgen receptor antagonists: selectivity switching by C/Si exchange., 21 (7): [PMID:23462715] [10.1016/j.bmc.2013.01.060] |
| 91. Kashiwagi H, Ono Y, Ohta M, Itoh S, Ichikawa F, Harada S, Takeda S, Sekiguchi N, Ishigai M, Takahashi T.. (2013) A series of nonsecosteroidal vitamin D receptor agonists for osteoporosis therapy., 21 (7): [PMID:23453218] [10.1016/j.bmc.2013.01.042] |
| 92. Matsuo M, Hasegawa A, Takano M, Saito H, Kakuda S, Chida T, Takagi K, Ochiai E, Horie K, Harada Y, Takimoto-Kamimura M, Takenouchi K, Sawada D, Kittaka A.. (2013) Synthesis of 2α-heteroarylalkyl active vitamin d3 with therapeutic effect on enhancing bone mineral density in vivo., 4 (7): [PMID:24900728] [10.1021/ml400098w] |
| 93. Demizu Y, Nagoya S, Shirakawa M, Kawamura M, Yamagata N, Sato Y, Doi M, Kurihara M.. (2013) Development of stapled short helical peptides capable of inhibiting vitamin D receptor (VDR)-coactivator interactions., 23 (15): [PMID:23806555] [10.1016/j.bmcl.2013.06.002] |
| 94. Fujishima T, Nozaki T, Suenaga T.. (2013) Design and synthesis of novel 1,25-dihydroxyvitamin D3 analogues having a spiro-oxetane fused at the C2 position in the A-ring., 21 (17): [PMID:23845283] [10.1016/j.bmc.2013.06.032] |
| 95. Nakabayashi M, Tsukahara Y, Iwasaki-Miyamoto Y, Mihori-Shimazaki M, Yamada S, Inaba S, Oda M, Shimizu M, Makishima M, Tokiwa H, Ikura T, Ito N.. (2013) Crystal structures of hereditary vitamin D-resistant rickets-associated vitamin D receptor mutants R270L and W282R bound to 1,25-dihydroxyvitamin D3 and synthetic ligands., 56 (17): [PMID:23944708] [10.1021/jm400537h] |
| 96. Chen B, Kawai M, Wu-Wong JR.. (2013) Synthesis of VS-105: A novel and potent vitamin D receptor agonist with reduced hypercalcemic effects., 23 (21): [PMID:24035340] [10.1016/j.bmcl.2013.08.076] |
| 97. Unpublished dataset, |
| 98. Huet T, Maehr H, Lee HJ, Uskokovic MR, Suh N, Moras D, Rochel N.. (2011) Structure-function study of gemini derivatives with two different side chains at C-20, Gemini-0072 and Gemini-0097., 2 (5): [PMID:22180837] [10.1039/c1md00059d] |
| 99. Mouriño A, Blair P, Wecksler W, Johnson RL, Norman AW, Okamura WH.. (1978) Studies on vitamin D (calciferol) and its analogues. 15. 24-Nor-1alpha,25-dihydroxyvitamin D3 and 24-nor-25-hydroxy-5,6-trans-vitamin D3., 21 (10): [PMID:214553] [10.1021/jm00208a005] |
| 100. Deberardinis AM, Madden DJ, Banerjee U, Sail V, Raccuia DS, De Carlo D, Lemieux SM, Meares A, Hadden MK.. (2014) Structure-activity relationships for vitamin D3-based aromatic a-ring analogues as hedgehog pathway inhibitors., 57 (9): [PMID:24730984] [10.1021/jm401812d] |
| 101. Kudo T, Ishizawa M, Maekawa K, Nakabayashi M, Watarai Y, Uchida H, Tokiwa H, Ikura T, Ito N, Makishima M, Yamada S.. (2014) Combination of triple bond and adamantane ring on the vitamin D side chain produced partial agonists for vitamin D receptor., 57 (10): [PMID:24773565] [10.1021/jm401989c] |
| 102. Anami Y, Itoh T, Egawa D, Yoshimoto N, Yamamoto K.. (2014) A mixed population of antagonist and agonist binding conformers in a single crystal explains partial agonism against vitamin D receptor: active vitamin D analogues with 22R-alkyl group., 57 (10): [PMID:24742174] [10.1021/jm500392t] |
| 103. Belorusova AY, Eberhardt J, Potier N, Stote RH, Dejaegere A, Rochel N.. (2014) Structural insights into the molecular mechanism of vitamin D receptor activation by lithocholic acid involving a new mode of ligand recognition., 57 (11): [PMID:24818857] [10.1021/jm5002524] |
| 104. Thomas E, Brion JD, Peyrat JF.. (2014) Synthesis and preliminary biological evaluation of new antiproliferative aromatic analogues of 1α,25-dihydroxyvitamin D3., 86 [PMID:25180926] [10.1016/j.ejmech.2014.07.037] |
| 105. Sibilska IK, Sicinski RR, Ochalek JT, Plum LA, DeLuca HF.. (2014) Synthesis and Biological Activity of 25-Hydroxy-2-methylene-vitamin D3 analogues monohydroxylated in the A-ring., 57 (20): [PMID:25221942] [10.1021/jm500750b] |
| 106. Liu C, Zhao GD, Mao X, Suenaga T, Fujishima T, Zhang CM, Liu ZP.. (2014) Synthesis and biological evaluation of 1α,25-dihydroxyvitamin D3 analogues with aromatic side chains attached at C-17., 85 [PMID:25127149] [10.1016/j.ejmech.2014.08.031] |
| 107. Ferla S, Aboraia AS, Brancale A, Pepper CJ, Zhu J, Ochalek JT, DeLuca HF, Simons C.. (2014) Small-molecule inhibitors of 25-hydroxyvitamin D-24-hydroxylase (CYP24A1): synthesis and biological evaluation., 57 (18): [PMID:25148392] [10.1021/jm5009314] |
| 108. Misawa T, Demizu Y, Kawamura M, Yamagata N, Kurihara M.. (2015) Structural development of stapled short helical peptides as vitamin D receptor (VDR)-coactivator interaction inhibitors., 23 (5): [PMID:25637122] [10.1016/j.bmc.2015.01.007] |
| 109. Deb S, Pandey M, Adomat H, Guns ES.. (2012) Cytochrome P450 3A-mediated microsomal biotransformation of 1α,25-dihydroxyvitamin D3 in mouse and human liver: drug-related induction and inhibition of catabolism., 40 (5): [PMID:22301272] [10.1124/dmd.111.041681] |
| 110. Drug metabolism data, |
| 111. Kulesza U, Plum LA, DeLuca HF, Mouriño A, Sicinski RR.. (2015) Novel 9-Alkyl- and 9-Alkylidene-Substituted 1α,25-Dihydroxyvitamin D3 Analogues: Synthesis and Biological Examinations., 58 (15): [PMID:26206427] [10.1021/acs.jmedchem.5b00795] |
| 112. Lin Z, Marepally SR, Ma D, Myers LK, Postlethwaite AE, Tuckey RC, Cheng CY, Kim TK, Yue J, Slominski AT, Miller DD, Li W.. (2015) Chemical Synthesis and Biological Activities of 20S,24S/R-Dihydroxyvitamin D3 Epimers and Their 1α-Hydroxyl Derivatives., 58 (19): [PMID:26367019] [10.1021/acs.jmedchem.5b00881] |
| 113. Anami Y, Sakamaki Y, Itoh T, Inaba Y, Nakabayashi M, Ikura T, Ito N, Yamamoto K.. (2015) Fine tuning of agonistic/antagonistic activity for vitamin D receptor by 22-alkyl chain length of ligands: 22S-Hexyl compound unexpectedly restored agonistic activity., 23 (22): [PMID:26515040] [10.1016/j.bmc.2015.10.026] |
| 114. Sibilska IK, Szybinski M, Sicinski RR, Plum LA, DeLuca HF.. (2015) Synthesis and Biological Activity of 2-Methylene Analogues of Calcitriol and Related Compounds., 58 (24): [PMID:26574921] [10.1021/acs.jmedchem.5b01295] |
| 115. Ge Z, Hao M, Xu M, Su Z, Kang Z, Xue L, Zhang C.. (2016) Novel nonsecosteroidal VDR ligands with phenyl-pyrrolyl pentane skeleton for cancer therapy., 107 [PMID:26562542] [10.1016/j.ejmech.2015.10.042] |
| 116. Watarai Y, Ishizawa M, Ikura T, Zacconi FC, Uno S, Ito N, Mouriño A, Tokiwa H, Makishima M, Yamada S.. (2015) Synthesis, Biological Activities, and X-ray Crystal Structural Analysis of 25-Hydroxy-25(or 26)-adamantyl-17-[20(22),23-diynyl]-21-norvitamin D Compounds., 58 (24): [PMID:26613420] [10.1021/acs.jmedchem.5b00792] |
| 117. Flores A, Massarelli I, Thoden JB, Plum LA, DeLuca HF.. (2015) A Methylene Group on C-2 of 24,24-Difluoro-19-nor-1α,25-dihydroxyvitamin D3 Markedly Increases Bone Calcium Mobilization in Vivo., 58 (24): [PMID:26630444] [10.1021/acs.jmedchem.5b01564] |
| 118. Teske KA, Bogart JW, Sanchez LM, Yu OB, Preston JV, Cook JM, Silvaggi NR, Bikle DD, Arnold LA.. (2016) Synthesis and evaluation of vitamin D receptor-mediated activities of cholesterol and vitamin D metabolites., 109 [PMID:26774929] [10.1016/j.ejmech.2016.01.002] |
| 119. Lin Z, Marepally SR, Ma D, Kim TK, Oak AS, Myers LK, Tuckey RC, Slominski AT, Miller DD, Li W.. (2016) Synthesis and Biological Evaluation of Vitamin D3 Metabolite 20S,23S-Dihydroxyvitamin D3 and Its 23R Epimer., 59 (10): [PMID:27070779] [10.1021/acs.jmedchem.6b00182] |
| 120. Smutny T, Nova A, Drechslerová M, Carazo A, Hyrsova L, Hrušková ZR, Kuneš J, Pour M, Špulák M, Pavek P.. (2016) 2-(3-Methoxyphenyl)quinazoline Derivatives: A New Class of Direct Constitutive Androstane Receptor (CAR) Agonists., 59 (10): [PMID:27145071] [10.1021/acs.jmedchem.5b01891] |
| 121. WHO Anatomical Therapeutic Chemical Classification, |
| 122. British National Formulary (72nd edition), |
| 123. DrugMatrix, [10.6019/CHEMBL3885881] |
| 124. Kato A, Yamao M, Hashihara Y, Ishida H, Itoh T, Yamamoto K.. (2017) Vitamin D Analogues with a p-Hydroxyphenyl Group at the C25 Position: Crystal Structure of Vitamin D Receptor Ligand-Binding Domain Complexed with the Ligand Explains the Mechanism Underlying Full Antagonistic Action., 60 (20): [PMID:28954197] [10.1021/acs.jmedchem.7b00819] |
| 125. Morgan RE, van Staden CJ, Chen Y, Kalyanaraman N, Kalanzi J, Dunn RT, Afshari CA, Hamadeh HK.. (2013) A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development., 136 (1): [PMID:23956101] [10.1093/toxsci/kft176] |
| 126. Chen M, Suzuki A, Thakkar S, Yu K, Hu C, Tong W.. (2016) DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans., 21 (4): [PMID:26948801] [10.1016/j.drudis.2016.02.015] |
| 127. Hao M, Hou S, Xue L, Yuan H, Zhu L, Wang C, Wang B, Tang C, Zhang C.. (2018) Further Developments of the Phenyl-Pyrrolyl Pentane Series of Nonsteroidal Vitamin D Receptor Modulators as Anticancer Agents., 61 (7): [PMID:29518319] [10.1021/acs.jmedchem.8b00106] |
| 128. Yoshizawa M, Itoh T, Hori T, Kato A, Anami Y, Yoshimoto N, Yamamoto K.. (2018) Identification of the Histidine Residue in Vitamin D Receptor That Covalently Binds to Electrophilic Ligands., 61 (14): [PMID:29936834] [10.1021/acs.jmedchem.8b00774] |
| 129. Otero R, Ishizawa M, Numoto N, Ikura T, Ito N, Tokiwa H, Mouriño A, Makishima M, Yamada S.. (2018) 25 S-Adamantyl-23-yne-26,27-dinor-1α,25-dihydroxyvitamin D3: Synthesis, Tissue Selective Biological Activities, and X-ray Crystal Structural Analysis of Its Vitamin D Receptor Complex., 61 (15): [PMID:29989817] [10.1021/acs.jmedchem.8b00427] |
| 130. Kang ZS, Wang C, Han XL, Du JJ, Li YY, Zhang C.. (2018) Design, synthesis and biological evaluation of non-secosteriodal vitamin D receptor ligand bearing double side chain for the treatment of chronic pancreatitis., 146 [PMID:29407979] [10.1016/j.ejmech.2018.01.073] |
| 131. Gogoi P, Seoane S, Sigüeiro R, Guiberteau T, Maestro MA, Pérez-Fernández R, Rochel N, Mouriño A.. (2018) Aromatic-Based Design of Highly Active and Noncalcemic Vitamin D Receptor Agonists., 61 (11): [PMID:29733645] [10.1021/acs.jmedchem.8b00337] |
| 132. Sampathi Perera KLI, Hanson AM, Lindeman S, Imhoff A, Lu X, Sem DS, Donaldson WA.. (2018) Synthesis and evaluation of 4-cycloheptylphenols as selective Estrogen receptor-β agonists (SERBAs)., 157 [PMID:30144697] [10.1016/j.ejmech.2018.08.006] |
| 133. Wang C, Wang B, Xue L, Kang Z, Hou S, Du J, Zhang C.. (2018) Design, Synthesis, and Antifibrosis Activity in Liver of Nonsecosteroidal Vitamin D Receptor Agonists with Phenyl-pyrrolyl Pentane Skeleton., 61 (23): [PMID:30350999] [10.1021/acs.jmedchem.8b01165] |
| 134. Kang ZS, Wang C, Han XL, Wang B, Yuan HL, Hou SY, Hao MX, Du JJ, Li YY, Zhou AW, Zhang C.. (2018) Sulfonyl-containing phenyl-pyrrolyl pentane analogues: Novel non-secosteroidal vitamin D receptor modulators with favorable physicochemical properties, pharmacokinetic properties and anti-tumor activity., 157 [PMID:30193216] [10.1016/j.ejmech.2018.08.085] |
| 135. Unpublished dataset, |
| 136. Bernhard Ellinger, Denisa Bojkova, Andrea Zaliani, Jindrich Cinatl, Carsten Claussen, Sandra Westhaus, Jeanette Reinshagen, Maria Kuzikov, Markus Wolf, Gerd Geisslinger, Philip Gribbon, Sandra Ciesek. (2020) Identification of inhibitors of SARS-CoV-2 in-vitro cellular toxicity in human (Caco-2) cells using a large scale drug repurposing collection, [10.21203/rs.3.rs-23951/v1] |
| 137. Cury NM, Capitão RM, Almeida RDCB, Artico LL, Corrêa JR, Simão Dos Santos EF, Yunes JA, Correia CRD.. (2019) Synthesis and evaluation of 2-carboxy indole derivatives as potent and selective anti-leukemic agents., 181 [PMID:31408809] [10.1016/j.ejmech.2019.111570] |
| 138. Misawa T, Tsuji G, Takahashi T, Ochiai E, Takagi KI, Horie K, Kakuda S, Takimoto-Kamimura M, Kurihara M, Demizu Y.. (2018) Structural development of non-secosteroidal vitamin D receptor (VDR) ligands without any asymmetric carbon., 26 (23-24): [PMID:30446437] [10.1016/j.bmc.2018.11.008] |
| 139. Maschinot CA, Chau LQ, Wechsler-Reya RJ, Hadden MK.. (2019) Synthesis and evaluation of third generation vitamin D3 analogues as inhibitors of Hedgehog signaling., 162 [PMID:30471551] [10.1016/j.ejmech.2018.11.028] |
| 140. Wang C, Wang B, Hou S, Xue L, Kang Z, Du J, Li Y, Liu X, Wang Q, Zhang C.. (2019) Discovery of novel nonsteroidal VDR agonists with novel diarylmethane skeleton for the treatment of breast cancer., 163 [PMID:30579121] [10.1016/j.ejmech.2018.12.024] |
| 141. Maria Kuzikov, Elisa Costanzi, Jeanette Reinshagen, Francesca Esposito, Laura Vangeel, Markus Wolf, Bernhard Ellinger, Carsten Claussen, Gerd Geisslinger, Angela Corona, Daniela Iaconis, Carmine Talarico, Candida Manelfi, Rolando Cannalire, Giulia Rossetti, Jonas Gossen, Simone Albani, Francesco Musiani, Katja Herzog, Yang Ye, Barbara Giabbai, Nicola Demitri, Dirk Jochmans, Steven De Jonghe, Jasper Rymenants, Vincenzo Summa, Enzo Tramontano, Andrea R. Beccari, Pieter Leyssen, Paola Storici, Johan Neyts, Philip Gribbon, and Andrea Zaliani. (2020) Identification of inhibitors of SARS-Cov2 M-Pro enzymatic activity using a small molecule repurposing screen, [10.6019/CHEMBL4495564] |
| 142. Andrea Zaliani, Laura Vangeel, Jeanette Reinshagen, Daniela Iaconis, Maria Kuzikov, Oliver Keminer, Markus Wolf, Bernhard Ellinger, Francesca Esposito, Angela Corona, Enzo Tramontano, Candida Manelfi, Katja Herzog, Dirk Jochmans, Steven De Jonghe, Winston Chiu, Thibault Francken, Joost Schepers, Caroline Collard, Kayvan Abbasi, Carsten Claussen , Vincenzo Summa, Andrea R. Beccari, Johan Neyts, Philip Gribbon and Pieter Leyssen. (2020) Cytopathic SARS-Cov2 screening on VERO-E6 cells in a large repurposing effort, [10.6019/CHEMBL4495565] |
| 143. Johannes Zuegg, Alysha Elliott, Maite Amado, Emma Cowie, Ali Hinton, Geraldine Kaeslin, Angela Kavanagh, Anne Kunert, Gabriell Lowe, Soumya Ramu, Janet Reid, Robin Trauer, Mathilde Desselle, Ruth Neale, Karl Hansford, Mark Blascovich, Matthew Cooper. CO-ADD screening of NIH (USA) - Clinical Collection, [10.6019/CHEMBL4513141] |
| 144. Belorusova AY, Chalhoub S, Rovito D, Rochel N.. (2020) Structural Analysis of VDR Complex with ZK168281 Antagonist., 63 (17): [PMID:32787090] [10.1021/acs.jmedchem.0c00656] |
| 145. Pellicciari R,Passeri D,De Franco F,Mostarda S,Filipponi P,Colliva C,Gadaleta RM,Franco P,Carotti A,Macchiarulo A,Roda A,Moschetta A,Gioiello A. (2016) Discovery of 3α,7α,11β-Trihydroxy-6α-ethyl-5β-cholan-24-oic Acid (TC-100), a Novel Bile Acid as Potent and Highly Selective FXR Agonist for Enterohepatic Disorders., 59 (19): [PMID:27652492] [10.1021/acs.jmedchem.6b01126] |
| 146. Sasaki H,Masuno H,Kawasaki H,Yoshihara A,Numoto N,Ito N,Ishida H,Yamamoto K,Hirata N,Kanda Y,Kawachi E,Kagechika H,Tanatani A. (2021) Lithocholic Acid Derivatives as Potent Vitamin D Receptor Agonists., 64 (1.0): [PMID:33369416] [10.1021/acs.jmedchem.0c01420] |
| 147. Bernhard Ellinger, Justus Dick, Vanessa Lage-Rupprecht, Bruce Schultz, Andrea Zaliani, Marcin Namysl, Stephan Gebel, Ole Pless, Jeanette Reinshagen, Christian Ebeling, Alexander Esser, Marc Jacobs, Carsten Claussen, and Martin Hofmann-Apitius. (2021) HDAC6 screening dataset using tau-based substrate in an enzymatic assay yields selective inhibitors and activators, [10.6019/CHEMBL4808148] |
| 148. Wen J, Hadden MK.. (2022) Affinity-based protein profiling identifies vitamin D3 as a heat shock protein 70 antagonist that regulates hedgehog transduction in murine basal cell carcinoma., 228 [PMID:34844141] [10.1016/j.ejmech.2021.114005] |
| 149. Seoane S, Gogoi P, Zárate-Ruíz A, Peluso-Iltis C, Peters S, Guiberteau T, Maestro MA, Pérez-Fernández R, Rochel N, Mouriño A.. (2022) Design, Synthesis, Biological Activity, and Structural Analysis of Novel Des-C-Ring and Aromatic-D-Ring Analogues of 1α,25-Dihydroxyvitamin D3., 65 (19.0): [PMID:36166643] [10.1021/acs.jmedchem.2c00900] |
| 150. Phull MS, Jadav SS, Gundla R, Mainkar PS.. (2021) A perspective on medicinal chemistry approaches towards adenomatous polyposis coli and Wnt signal based colorectal cancer inhibitors., 212 [PMID:33445154] [10.1016/j.ejmech.2020.113149] |
| 151. Sutherland JJ, Yonchev D, Fekete A, Urban L.. (2023) A preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugs., 14 (1): [PMID:37468498] [10.1038/s41467-023-40064-9] |
| 152. EUbOPEN. (2023) EUbOPEN Chemogenomics Library - IncuCyte, [10.6019/CHEMBL5303304] |
| 153. EUbOPEN. (2023) Tm Shift (DSF) assay results for EUbOPEN Chemogenomics Library, [10.6019/CHEMBL5308504] |
| 154. Unpublished dataset, |
